Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4173144 | Paediatrics and Child Health | 2009 | 7 Pages |
Abstract
Congenital cytomegalovirus (CMV) is the commonest congenital infection in the developed world with an estimated prevalence of 0.18–6.2% of all births. Despite recognition for many decades of CMV as an important contributor to neurodevelopmental and hearing impairment in infants, little progress has been made with regards to prevention and treatment of this often overlooked infection. In the past ten years, however, research has addressed many important aspects of diagnosis, prognosis, treatment and prevention of congenital CMV. This review summarizes the more important of these advances as they apply to management of babies born with CMV.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
Suzanne Luck, Mike Sharland,